<DOC>
	<DOCNO>NCT00241982</DOCNO>
	<brief_summary>Trial study safety single , intravenous administration long-circulating liposomal prednisolone disodium phosphate patient active rheumatoid arthritis .</brief_summary>
	<brief_title>Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description>A proof concept , dose-escalating trial study safety single , intravenous administration long-circulating liposomal prednisolone disodium phosphate patient active rheumatoid arthritis . Secondary goal : To compare therapeutic effect intervention single intramuscular administration 120 mg methylprednisolone ( Depo-Medrol , Pharmacia ) . The latter commonly use clinic bridge therapy . To assess effect intervention synovial tissue level . On long term , goal liposomal corticosteroid achieve increase efficacy/safety ratio compare standard treatment free corticosteroid .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>In order enrol study patient must : Be age 18 year old Fulfill revise 1987 ARA criterion classification RA Have active RA define Modified Disease Activity Score ( DAS28 ) 3.2 Have stable treatment disease modify antirheumatic drug within 12 week prior trial initiation Be able willing give voluntary write informed consent The indication bridge therapy systemic corticosteroid establish care rheumatologist The patient must Have treat oral corticosteroid within 2 week prior baseline intraarticular intramuscular corticosteroid within 8 week prior baseline Have diabetes mellitus abnormal renal , liver haematological test Have clinically severe unstable medical condition involve cardiac , pulmonary , liver endocrine disorder malignancy Have previous history bleed infectious disorder Be currently pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>long circulate liposome</keyword>
</DOC>